CCRM, OmniaBio and Avectas Partner to Improve Cell Therapy Manufacturing
DUBLIN and TORONTO, June 15, 2026 /PRNewswire/ - CCRM and its CDMO subsidiary OmniaBio Inc., today announced an agreement with Avectas Limited ("Avectas") to evaluate its automated, integrated and scalable cell therapy manufacturing platform. The evaluation will explore how Avectas'...
DUBLIN and TORONTO, June 15, 2026 /PRNewswire/ - CCRM and its CDMO subsidiary OmniaBio Inc., today announced an agreement with Avectas Limited ("Avectas") to evaluate its automated, integrated and scalable cell therapy manufacturing platform. The evaluation will explore how Avectas'...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.